z-logo
open-access-imgOpen Access
A model of the onset of the senescence associated secretory phenotype after DNA damage induced senescence
Author(s) -
Patrick E. Meyer,
Pallab Maity,
Andreas Burkovski,
Julian Schwab,
Christoph Müssel,
Karmveer Singh,
Filipa F. Ferreira,
Linda Krug,
Harald J. Maier,
Meinhard Wlaschek,
Thomas Wirth,
Hans A. Kestler,
Karin Scharffetter­Kochanek
Publication year - 2017
Publication title -
plos computational biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.628
H-Index - 182
eISSN - 1553-7358
pISSN - 1553-734X
DOI - 10.1371/journal.pcbi.1005741
Subject(s) - in silico , senescence , dna damage , phenotype , gene knockout , microbiology and biotechnology , biology , regulator , gene , mechanism (biology) , inflammation , gene regulatory network , in vitro , knockout mouse , dna , gene expression , genetics , immunology , philosophy , epistemology
Cells and tissues are exposed to stress from numerous sources. Senescence is a protective mechanism that prevents malignant tissue changes and constitutes a fundamental mechanism of aging. It can be accompanied by a senescence associated secretory phenotype (SASP) that causes chronic inflammation. We present a Boolean network model-based gene regulatory network of the SASP, incorporating published gene interaction data. The simulation results describe current biological knowledge. The model predicts different in-silico knockouts that prevent key SASP-mediators, IL-6 and IL-8, from getting activated upon DNA damage. The NF-κB Essential Modulator (NEMO) was the most promising in-silico knockout candidate and we were able to show its importance in the inhibition of IL-6 and IL-8 following DNA-damage in murine dermal fibroblasts in-vitro . We strengthen the speculated regulator function of the NF-κB signaling pathway in the onset and maintenance of the SASP using in-silico and in-vitro approaches. We were able to mechanistically show, that DNA damage mediated SASP triggering of IL-6 and IL-8 is mainly relayed through NF-κB, giving access to possible therapy targets for SASP-accompanied diseases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom